People

Keith Blundy
Life-sciences commercialization adviser and company chair. Former STORM Therapeutics CEO and CancerResearchTechnology executive; he helped develop academic drug-discovery partnerships and the CRT Pioneer Fund. CD3 identifies him as an investment-committee member.
Roles
KU Leuven
CurrentCD3 Investment Committee Member (external committee affiliation)